Literature DB >> 11757582

Decreased half-life of insulin-like growth factor I in Rabson-Mendenhall syndrome.

N Longo1, R Singh, L J Elsas.   

Abstract

Rabson-Mendenhall syndrome is an autosomal recessive disorder of insulin signalling caused by mutations in the insulin receptor gene. Affected patients are insensitive to exogenous insulin. Insulin-like growth factor I (IGF-I), whose receptor is similar to the one for insulin and is not impaired in this condition, is not always effective in these patients. To understand the reason for this failure, IGF-I concentrations were measured in a patient after subcutaneous injection of 0.1 and 0.2 mg/kg of rhIGF-I. IGF-I concentrations increased only transiently because of the short half-life (1.3-3 h, compared to a normal range of 17-22 h). No correlation was found between IGF-I concentrations and glucose or insulin concentrations. The short half-life of IGF-I may contribute to treatment failure in patients with inherited insulin-resistant syndromes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757582     DOI: 10.1023/a:1012411709972

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

Review 1.  Insulin-like growth factors in pediatric health and disease.

Authors:  D Le Roith; A A Butler
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

2.  Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.

Authors:  J D Quin; B M Fisher; K R Paterson; A Inoue; G H Beastall; A C MacCuish
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

3.  Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.

Authors:  J Nakae; M Kato; M Murashita; N Shinohara; T Tajima; K Fujieda
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

4.  Leprechaunism and homozygous nonsense mutation in the insulin receptor gene.

Authors:  H Psiachou; S Mitton; J Alaghband-Zadeh; J Hone; S I Taylor; L Sinclair
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

5.  Progressive decline in insulin levels in Rabson-Mendenhall syndrome.

Authors:  N Longo; Y Wang; M Pasquali
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

6.  Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes.

Authors:  H Kuzuya; N Matsuura; M Sakamoto; H Makino; Y Sakamoto; T Kadowaki; Y Suzuki; M Kobayashi; Y Akazawa; M Nomura
Journal:  Diabetes       Date:  1993-05       Impact factor: 9.461

7.  Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency.

Authors:  A Grahnén; K Kastrup; U Heinrich; M Gourmelen; M A Preece; M A Vaccarello; J Guevara-Aguirre; R G Rosenfeld; A Sietnieks
Journal:  Acta Paediatr Suppl       Date:  1993-09

8.  Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance.

Authors:  E J Schoenle; P D Zenobi; T Torresani; E A Werder; M Zachmann; E R Froesch
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

9.  Effect of intravenous insulin-like growth factor I in two patients with leprechaunism.

Authors:  P F Backeljauw; C Alves; M Eidson; W Cleveland; L E Underwood; M L Davenport
Journal:  Pediatr Res       Date:  1994-12       Impact factor: 3.756

10.  Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.

Authors:  N Longo; R Singh; L D Griffin; S D Langley; J S Parks; L J Elsas
Journal:  J Clin Endocrinol Metab       Date:  1994-09       Impact factor: 5.958

  10 in total
  8 in total

1.  Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome.

Authors:  David R Weber; Diana E Stanescu; Robert Semple; Cheryl Holland; Sheela N Magge
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

2.  Pharmacodynamic considerations with recombinant human insulin-like growth factor-I in children.

Authors:  Robert J Ferry; Pinchas Cohen; Lorraine E Levitt Katz
Journal:  Horm Res       Date:  2005-05-09

3.  First molecular diagnosis of Donohue syndrome in Africa: novel unusual insertion/deletion mutation in the INSR gene.

Authors:  Olfa Siala-Sahnoun; Dhoha Dhieb; Afef Ben Thabet; Nedia Hmida; Neila Belguith; Faiza Fakhfakh
Journal:  Mol Biol Rep       Date:  2016-02-13       Impact factor: 2.316

4.  Rabson-Mendenhall syndrome: medullary sponge kidney, a new component.

Authors:  Andrew M Harris; Bryan Hall; Vesna M Kriss; John L Fowlkes; Stefan G Kiessling
Journal:  Pediatr Nephrol       Date:  2007-09-12       Impact factor: 3.714

5.  Computational Analysis of Damaging Single-Nucleotide Polymorphisms and Their Structural and Functional Impact on the Insulin Receptor.

Authors:  Zabed Mahmud; Syeda Umme Fahmida Malik; Jahed Ahmed; Abul Kalam Azad
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

6.  Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene.

Authors:  O Ardon; M Procter; T Tvrdik; N Longo; R Mao
Journal:  Mol Genet Metab Rep       Date:  2014-02-11

Review 7.  Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.

Authors:  Michaela Plamper; Bettina Gohlke; Felix Schreiner; Joachim Woelfle
Journal:  Int J Mol Sci       Date:  2018-04-24       Impact factor: 5.923

8.  Rabson-mendenhall syndrome.

Authors:  Iffat Hassan; Hinah Altaf; Atiya Yaseen
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.